Green Lifescience Co., Ltd. (KOSDAQ: 114450)

Green Lifescience Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	7,495	6,348	2,814	3,388	2,402	7,514
Short-Term Investments	2,022	3,669	2,300	7,800	7,800	10,032
Trading Asset Securities	4,034	4,436	11,835	5,015	4,930	2,961
Cash & Short-Term Investments	13,551	14,453	16,949	16,203	15,133	20,507
Cash Growth	-7.69%	-14.73%	4.60%	7.08%	-26.21%	-0.15%
Accounts Receivable	1,962	1,451	2,509	3,450	1,753	5,451
Other Receivables	110.13	8.54	333.75	114.13	284.56	123.38
Receivables	2,072	1,460	2,843	3,564	2,037	5,574
Inventory	4,543	5,311	6,014	5,732	6,649	4,892
Prepaid Expenses	150.88	160.15	42.62	735.77	438.83	595.21
Other Current Assets	136.45	328.73	595.04	657.55	314.22	93.81
Total Current Assets	20,454	21,712	26,443	26,892	24,572	31,662
Property, Plant & Equipment	13,418	13,256	27,112	36,846	35,626	35,079
Long-Term Investments	-	-	-	7,381	9,912	3,916
Other Intangible Assets	2.38	2.81	87.92	181.72	370.26	558.63
Long-Term Deferred Tax Assets	-	-	-	619.37	355.14	566.61
Long-Term Deferred Charges	13.38	24.91	-	-	-	102.34
Other Long-Term Assets	9,212	8,833	8,788	57.44	12.08	10
Total Assets	43,101	43,828	62,432	71,977	70,846	71,894
Accounts Payable	-	-	-	4,114	2,835	2,538
Accrued Expenses	-	-	-	2.12	136.07	180.91
Short-Term Debt	4,800	4,800	6,488	7,433	6,211	5,100
Current Portion of Leases	150.63	104.04	117.85	104.86	170.18	160.18
Current Unearned Revenue	34	34	34	-	-	-
Other Current Liabilities	1,930	2,455	2,796	3,588	1,429	3,093
Total Current Liabilities	6,915	7,394	9,437	15,242	10,781	11,072
Long-Term Leases	51.58	28.82	18.27	57.76	31.42	-
Other Long-Term Liabilities	9.62	8.12	6.78	8.19	6.67	8.98
Total Liabilities	7,495	7,874	9,793	15,679	11,475	11,537
Common Stock	10,000	10,000	7,500	7,500	7,500	7,500
Additional Paid-In Capital	15,025	36,425	38,956	38,956	38,956	38,956
Retained Earnings	12,604	-10,105	6,232	9,680	12,820	13,892
Treasury Stock	-2,023	-366.29	-	-	-	-
Comprehensive Income & Other	-0	0	-48.7	162.39	95.97	9.77
Shareholders' Equity	35,605	35,954	52,639	56,298	59,371	60,358
Total Liabilities & Equity	43,101	43,828	62,432	71,977	70,846	71,894
Total Debt	5,002	4,933	6,624	7,595	6,413	5,260
Net Cash (Debt)	8,549	9,520	10,324	8,608	8,720	15,247
Net Cash Growth	-3.90%	-7.79%	19.93%	-1.28%	-42.81%	-1.23%
Net Cash Per Share	440.80	476.93	515.40	430.30	438.28	765.05
Filing Date Shares Outstanding	19.09	19.83	20	20	20	20
Total Common Shares Outstanding	19.09	19.83	20	20	20	20
Working Capital	13,539	14,319	17,007	11,651	13,791	20,590
Book Value Per Share	1865.38	1812.66	2631.95	2814.92	2968.56	3017.88
Tangible Book Value	35,603	35,951	52,551	56,117	59,001	59,799
Tangible Book Value Per Share	1865.26	1812.52	2627.55	2805.83	2950.04	2989.95
Land	8,425	8,425	8,329	7,923	7,923	7,923
Buildings	7,846	7,846	16,077	13,381	13,381	13,309
Machinery	35,549	35,434	38,766	39,913	37,596	37,364
Construction In Progress	403.08	23.1	207.03	11,769	10,758	8,395

Source: S&P Capital IQ. Standard template. Financial Sources.